Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Divi's Laboratories Ltd.
NSE: DIVISLAB
|
BSE: 532488
|
ISIN: INE361B01024
|
Industry: Pharmaceuticals
|
Expensive Star
6888.5000
-18.00
(
-0.26
%)
NSE
Jul 07, 2025
15:31 PM
New 52W High in past week
Volume:
85,574
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Divi's Laboratories Ltd.
22 May 2023
6888.50
-0.26%
Healthy pick-up in API sales drives earnings
Neutral:
Divi's Laboratories Ltd.
by
Motilal Oswal
Target: 2900
Target
Motilal Oswal
Divi's Laboratories Ltd. has gained
48.79%
in the last 1 Year
More from Divi's Laboratories Ltd.
Recommended
As IPO fever hits new high, Crizac and three other listings on the horizon
|
07 Jul 2025, 05:34PM
Market closes flat, Sharda Motor's board approves 1:1 bonus share allotment
Trendlyne Marketwatch |
07 Jul 2025, 03:55PM
Custom synthesis business drives growth for Divi’s Laboratories
|
10 Mar 2022